Advanced search
Log in
Log in
Or log in with
GoogleGoogle
Twitter Twitter
Facebook Facebook
Apple Apple     
Sign up
Email Registration
Or log in with
GoogleGoogle
Twitter Twitter
Facebook Facebook
Apple Apple     
  1. Homepage
  2. Equities
  3. United States
  4. Nasdaq
  5. 10x Genomics, Inc.
  6. Consensus
    TXG   US88025U1097

10X GENOMICS, INC.

(TXG)
  Report
Delayed Nasdaq  -  04:00:00 2023-01-27 pm EST
48.65 USD   +1.29%
01/1910x Genomics to Report Fourth Quarter and Full Year 2022 Financial Results on February 15, 2023
PR
01/09Transcript : 10x Genomics, Inc. Presents at 41st Annual J.P. Morgan Healthcare Conference, Jan-08-2023 through Jan-12-2023
CI
01/05Cornell University : Method precisely locates gene activity and proteins across tissues
AQ
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisionsFunds 
Evolution of the average Target Price on 10X GENOMICS, INC.
Target Price consensus revisions : last 18 months
Recommendations (Chart) 10X GENOMICS, INC.
Analyst Recommendations on 10X GENOMICS, INC.
2022Deutsche Bank Initiates Coverage on 10x Genomics With Buy Rating, $50 Price Target
MT
2022Morgan Stanley Adjusts Price Target on 10x Genomics to $64 From $70, Maintains Overweight ..
MT
2022Goldman Sachs Lowers Price Target on 10x Genomics to $25 From $35, Maintains Sell Rating
MT
2022Goldman Sachs Downgrades 10x Genomics to Sell From Neutral, Lowers Price Target to $35 Fro..
MT
2022Morgan Stanley Adjusts 10x Genomics' Price Target to $70 from $100, Keeps Overweight Ratin..
MT
2022Analyst recommendations: Target, Glencore, Fidelity National Information Services, Moody's..
MS
2022Stifel Nicolaus Adjusts 10x Genomics Price Target to $65 From $115, Maintains Buy Rating
MT
More recommendations
Consensus
Sell
Buy
Mean consensus OUTPERFORM
Number of Analysts 10
Last Close Price 48,65 $
Average target price 49,67 $
Spread / Average Target 2,09%
High Price Target 65,00 $
Spread / Highest target 33,6%
Low Price Target 25,00 $
Spread / Lowest Target -48,6%
Consensus detail
Consensus revision (last 18 months)